Carl L. Herndon, MD

As the Chief of the Maternal Fetal Medicine (MFM) division and the Hillary Rodham Clinton Professor of Women's Health, Dr. Simpson supports a skilled team of physicians with expertise in maternal medicine, critical-care obstetrics, prenatal pediatrics, high-risk deliveries, and research, offering the best maternal and fetal care in the region. She also serves as a leader at CUIMC's Carmen and John Thain Center for Prenatal Pediatrics, where patients with pregnancies complicated by fetal malformations, genetic syndromes, or multiple gestations receive comprehensive, multidisciplinary care in a state-of-the-art facility. As former Director of CUIMC's Ob/Gyn Ultrasound program, she has assembled an outstanding group of sonographers and physicians to provide the best available sonographic imaging to women with high-risk pregnancies. Dr. Simpson's specialized training in fetal echocardiography complements her expertise in prenatal diagnosis. She performs invasive fetal procedures such as chorionic villus sampling, amniocentesis, fetal blood sampling, and others required in complex cases, including, fetoscopy and laser photocoagulation for twin-twin transfusion syndrome. Dr. Simpson has served on the board of directors for the Society of Maternal Fetal Medicine, and was a recipient of the Leonard Tow Humanism in Medicine Award in 2010.

Dr. Elaine Wan is the Esther Aboodi Associate Professor of Medicine in Cardiology and Cardiac Electrophysiology at Columbia University Medical Center, College of Physicians and Surgeons and attending physician at NewYork-Presbyterian Hospital. She is trained in Internal Medicine, Clinical Cardiology and is an invasive cardiac electrophysiologist. She is the Director of Electrophysiology Research and oversees all electrophysiology clinical trials. She performs implantation of cardiac devices including pacemaker and defibrillators, as well as ablation of arrhythmias. Dr. Wan is a physician-scientist and focuses on development of novel treatments for heart failure, vascular dysfunction and arrhythmias such as atrial fibrillation. She is a translational researcher also interested in development of innovative imaging modalities to improve ablation delivery. Dr. Wan is a graduate of the Massachusetts Institute of Technology. She received her medical degree from Columbia University College of Physicians and Surgeons and completed her fellowship in Cardiovascular Diseases and Clinical Cardiac Electrophysiology at NewYork-Presbyterian/Columbia. Dr. Wan is on the Board of Trustees of the Heart Rhythm Society. She is the Chairperson for the NIH Study Section of Imaging Technology Development. She is also the Chairperson-elect for the American Heart Association Committee on Arrhythmia and Electrophysiology. Dr. Wan is the recipient of numerous national and international awards including NIH R01s, R03, K08, the 2016 American College of Cardiology Young Investigator Award First Place in Molecular Cellular Cardiology, 2016 Young Physician Investigator Award from the American Society of Clinical Investigators, 2016 Cardiostim/Europace Best Young EP Presentation (Nice, France) and the 2008 American Heart Association Women in Cardiology for Clinical Excellence.She is the recipient of several competitive research grants including NIH NHLBI K08 Mentored Career Development Award, NIH NHLBI R03 Small Grant Program and NIH NHLBI R01 to study the use of 3D mitochondrial dysfunction imaging in cardiac arrhythmias. She is also a recipient of the American Heart Association Scientist Development Grant, grant support from the Foundation of Gender Specific Medicine, Columbia University Louis V. Gerstner Jr. Scholars Program, and Columbia University Provost's Grants Program for Junior Faculty who Contribute to the Diversity Goals of the University. She is vice co-chair of the Heart Rhythm Society Digital Health Committee and a member of the American Heart Association Committee on Electrocardiography and Arrhythmias. She has published over 100 manuscripts in high impact journals such as Nature Medicine, Circulation, Science Translational Medicine, Circulation Research, Journal of Clinical Investigation and Journal of American College of Cardiology. She has written 3 book chapters and given invited talks around the world.

Dr. Debkumar Sarkar, DO, MBA, FSIR is a board-certified interventional radiologist. He is an assistant professor of radiology at Columbia University Irving Medical Center and an attending radiologist at NewYork-Presbyterian Hospital. Dr. Sarkar serves as director of outpatient interventional radiology services for the Department of Radiology. Dr. Sarkar has extensive experience in interventional oncology and cancer diagnosis and treatment. He is locally and nationally renowned for treatment of metastatic tumors in the liver, lung, and kidneys. Dr. Sarkar has extensive experience with minimally invasive techniques including Y90 radioembolization, microwave ablation, cryoablation, and histotripsy for primary and metastatic cancers including hepatocellular carcinoma, colon cancer, and metastatic breast cancer. In addition to cancer therapy, Dr. Sarkar brings expertise in the treatment of venous disorders including deep venous thrombosis, venous thromboembolism, and vascular insufficiency. Dr. Sarkar has extensive experience treating complex biliary disorders and performs cholangioscopy. He is also very experienced in women’s health treatments for pelvic pain related to fibroids and pelvic congestion syndrome. Dr. Sarkar performs pain management and spine related procedures such as vertebroplasty and kyphoplasty. He also works in conjunction with urologists in the treatment of male infertility and urinary obstruction. Dr. Sarkar completed his undergraduate training in biomedical engineering at Northwestern University. He completed medical school training at Rowan University, followed by a Masters in Business Administration from University of Massachusetts Amherst. Dr. Sarkar completed an internship at UPMC Mercy Hospital in Pittsburgh, Pennsylvania and a residency in diagnostic radiology at Cooper University Hospital and MD Anderson Cancer Center of NJ in Camden, NJ. He subsequently completed a fellowship in vascular and interventional radiology and interventional oncology at Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center/New York Presbyterian Hospital. Dr. Sarkar served as chief of interventional radiology at Maimonides Medical Center in Brooklyn and subsequently joined the faculty at Memorial Sloan Kettering Cancer Center before being recruited to Columbia. Dr. Sarkar has published on numerous topics in IR including treatment of metastatic cancers in the liver with radioembolization and ablation and various topics involving robotics, artificial intelligence, and informatics. He is a member of the Society of Interventional Radiology and the Society of Interventional Oncology where he serves on several national committees including the SIR Economics committee and the expert consensus panel for management of pulmonary embolism.